AU2003229736A1 - Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1) - Google Patents

Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1)

Info

Publication number
AU2003229736A1
AU2003229736A1 AU2003229736A AU2003229736A AU2003229736A1 AU 2003229736 A1 AU2003229736 A1 AU 2003229736A1 AU 2003229736 A AU2003229736 A AU 2003229736A AU 2003229736 A AU2003229736 A AU 2003229736A AU 2003229736 A1 AU2003229736 A1 AU 2003229736A1
Authority
AU
Australia
Prior art keywords
therapeutics
diagnostics
diseases associated
neurotensin receptor
neurotensin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003229736A
Inventor
Ulf Bruggemeier
Stefan Golz
Holger Summer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2003229736A1 publication Critical patent/AU2003229736A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003229736A 2002-05-02 2003-04-28 Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1) Abandoned AU2003229736A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02009312 2002-05-02
EP02009312.6 2002-05-02
PCT/EP2003/004397 WO2003093828A1 (en) 2002-05-02 2003-04-28 Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1)

Publications (1)

Publication Number Publication Date
AU2003229736A1 true AU2003229736A1 (en) 2003-11-17

Family

ID=29286097

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003229736A Abandoned AU2003229736A1 (en) 2002-05-02 2003-04-28 Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1)

Country Status (2)

Country Link
AU (1) AU2003229736A1 (en)
WO (1) WO2003093828A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8586043B2 (en) 2009-01-07 2013-11-19 Inserm ( Institut National De La Sante Et De La Recherche Medicale) Methods for treating breast cancer with inhibitors of neurotensin activation of NTSR1
CA3109726A1 (en) * 2018-08-31 2020-03-05 Immune Biosolutions Inc Antibodies specific for ntsr1 and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1420929A (en) * 2000-04-07 2003-05-28 阿瑞那制药公司 Non-endogenous, constitutively activated known G protein-coupled receptors
IL142707A0 (en) * 2000-04-27 2002-03-10 Pfizer Prod Inc Methods of treating obesity using a neurotensin receptor ligand

Also Published As

Publication number Publication date
WO2003093828A1 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
AU2003251471A1 (en) Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 5(cxcr5)
AU2003214249A1 (en) Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1)
AU2003214072A1 (en) Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1)
AU2003229736A1 (en) Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1)
AU2003229767A1 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9)
AU2003273994A1 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43)
AU2003205627A1 (en) Diagnostics and therapeutics for diseases associated with gpr72
AU2003240589A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 4 (gpr4)
AU2003240720A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 5 (sstr5)
AU2003240468A1 (en) Diagnostics and therapeutics for diseases associated with neurotensin receptor 2 (nt2)
AU2003229753A1 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8)
AU2003250221A1 (en) Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 6(cxcr6)
AU2003250128A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37)
AU2003267443A1 (en) Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41)
AU2003216866A1 (en) Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
AU2003206749A1 (en) Diagnostics and therapeutics for diseases associated with the gpr65 receptor
AU2003283427A1 (en) Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1)
AU2003218638A1 (en) Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
AU2003240721A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 4(sstr4)
AU2003227751A1 (en) Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 1 (avpr1)
AU2003240639A1 (en) Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 3 (avpr3)
AU2003279361A1 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7B (PDE7b)
AU2003276097A1 (en) Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42)
AU2003221502A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 10 (gpr10)
AU2003301892A1 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 3 (gpr3)

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase